Evidence map›Paper›PMID 9882346›Full record

ArticleJournal of virology1999

Human parainfluenza virus type 3 up-regulates major histocompatibility complex class I and II expression on respiratory epithelial cells: involvement of a STAT1- and CIITA-independent pathway.

J Gao, B P De, A K Banerjee

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 44 citations in OpenAlex.

  1. Single-cell resolution of human airway epithelial cells exposed to bronchiolitis obliterans-associated chemicals.American journal of physiology. Lung cellular and molecular physiology · 2024
    Article
  2. Article
  3. Cytotoxic CD4Frontiers in immunology · 2023
    Review
  4. Review
  5. NOD-like receptors in asthma.Frontiers in immunology · 2022
    Review
  6. Article
  7. Review
  8. Review
  9. CD4 CTL, a Cytotoxic Subset of CD4Frontiers in immunology · 2017
    Review
  10. Article
  11. CD4 CTL: living up to the challenge.Seminars in immunology · 2013
    Review
  12. Article
  13. FIZZ2/RELM-β induction and role in pulmonary fibrosis.Journal of immunology (Baltimore, Md. : 1950) · 2011
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Temporal activation of NF-kappaB regulates an interferon-independent innate antiviral response against cytoplasmic RNA viruses.Proceedings of the National Academy of Sciences of the United States of America · 2003
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

J GaoDepartment of Virology, The Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
B P De
A K Banerjee
Cleveland Clinic · US

Funding

HOST/VIRUS INTERACTION AND GENE EXPRESSIONR01AI032027 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI BANERJEE, AMIYA K. · 1992 to 2006
$2.5M
NIAID NIH HHS AI32027NIAID NIH HHS R01 AI032027
6 · The paper itself

Abstract

Human parainfluenza virus type 3 (HPIV3) infection causes severe damage to the lung epithelium, leading to bronchiolitis, pneumonia, and croup in newborns and infants. Cellular immunity that plays a vital role in normal antiviral action appears to be involved, possibly because of inappropriate activation, in the infection-related damage to the lung epithelium. In this study, we investigated the expression of major histocompatibility complex (MHC) class I and II molecules on human lung epithelial (A549) and epithelium-like (HT1080) cells following HPIV3 infection. MHC class I was induced by HPIV3 in these cells at levels similar to those observed with natural inducers such as beta and gamma interferon (IFN-beta and -gamma). MHC class II was also efficiently induced by HPIV3 in these cells. UV-irradiated culture supernatants from infected cells were able to induce MHC class I but not MHC class II, suggesting involvement of released factors for the induction of MHC class I. Quantitation of IFN types I and II in the culture supernatant showed the presence of IFN-beta as the major cytokine, while IFN-gamma was undetectable. Anti-IFN-beta, however, blocked the HPIV3-mediated induction of MHC class I only partially, indicating that viral antigens, besides IFN-beta, are directly involved in the induction process. The induction of MHC class I and class II directed by the viral antigens was confirmed by using cells lacking STAT1, an essential intermediate of the IFN signaling pathways. HPIV3 induced both MHC class I and class II molecules in STAT1-null cells. Furthermore, MHC class II was also induced by HPIV3 in cells defective in class II transactivator, an important intermediate of the IFN-gamma-mediated MHC class II induction pathway. Together, these data indicate that the HPIV3 gene product(s) is directly involved in the induction of MHC class I and II molecules. The induction of MHC class I and II expression by HPIV3 suggests that it plays a role in the infection-related immunity and pathogenesis.

Indexed as

Nuclear ProteinsUp-RegulationAnimalsCell LineChlorocebus aethiopsCulture Media, ConditionedDNA-Binding ProteinsEpithelial CellsHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHumansLungParainfluenza Virus 3, HumanSTAT1 Transcription FactorTrans-ActivatorsTumor Cells, CulturedCulture Media, ConditionedDNA-Binding ProteinsHistocompatibility Antigens Class IHistocompatibility Antigens Class IIMHC class II transactivator proteinNuclear ProteinsSTAT1 protein, humanSTAT1 Transcription FactorTrans-Activators

Identifiers

PMID9882346
PMCPMC103965
OpenAlexW2150782741

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.